Search
Search Results
##search.searchResults.foundPlural##
-
FOLLICULAR LYMPHOMA: THE MANAGEMENT OF ELDERLY PATIENT
4444PDF: 1645HTML: 4037Tables and Images: 228 -
INFECTIONS AND FOLLICULAR LYMPHOMA: IS THERE A LINK?
3251PDF: 1019HTML: 2031 -
THERAPY-RELATED MYELOID NEOPLASM IN NON-HODGKIN LYMPHOMA SURVIVORS
2599PDF: 752HTML: 2309 -
EBV-RELATED LYMPHOPROLIFERATIVE DISEASES: A REVIEW IN LIGHT OF NEW CLASSIFICATIONS EBV-RELATED LYMPHOPROLIFERATIVE DISEASES
4141PDF: 1714HTML: 1028 -
LIMITED STAGE FOLLICULAR LYMPHOMA: THE ROLE OF RADIATION THERAPY.
3723PDF: 1107HTML: 2348Figure 1: 211 -
HEPATITIS C VIRUS INFECTION AND LYMPHOMA
1012PDF: 549HTML: 7815 -
PLASMABLASTIC LYMPHOMA. A STATE-OF-THE-ART REVIEW (1) Part 1- Epidemiology, pathogenesis, clinicopathologic characteristics, differential diagnosis, prognostic factors and special populations
3577PDF: 2506HTML: 1492 -
NOVEL DRUGS IN FOLLICULAR LYMPHOMA
4345PDF: 1513HTML: 1553Untitled: 236 -
HHVs AND LYMPHOPROLIFERATIVE DISORDERS
1415PDF: 823HTML: 3123 -
THE ROLE OF AUTOLOGOUS AND ALLOGENEIC STEM CELL TRANSPLANTATION IN FOLLICULAR LYMPHOMA IN THE NEW DRUGS ERA.
4076PDF: 1156HTML: 1952Fig.1: 219Fig. 2: 113Table 1: 204Table2: 222Table 3: 202 -
SYSTEMIC MASTOCYTOSIS: MULTIDISCIPLINARY APPROACH Systemic Mastocytosis
1564PDF: 1035HTML: 234 -
Follicular Lymphoma: A Clinicopathological Analysis from a Tertiary care Institute in Southern India
3217PDF: 783HTML: 2967Figure 1a and 1b: 150Figure 2: 161Figure 3: 179Figure 4: 163Figure 5: 165Tables 1-5: 154 -
PATHOBIOLOGY OF HODGKIN LYMPHOMA
3254PDF: 1457HTML: 5952Fig1-Ag-Pil: 230Ag-Pil Fig.2: 233 -
WALDENSTROM’S MACROGLOBULINEMIA: AN UPDATE
7648PDF: 2434HTML: 1739Table 1.: 213Table 2.: 222Table 3.: 205Table 4.: 205 -
IMMUNOTHERAPY FOR EPSTEIN-BARR VIRUS-RELATED LYMPHOMAS
1181PDF: 606HTML: 6801 -
TOXICITIES ASSOCIATED WITH CAR-T CELL THERAPIES CAR-T Cell Toxicity
2270PDF: 1623HTML: 274 -
Pathologic splenic rupture in a patient with follicular lymphoma
1437PDF: 556HTML: 1195rupture: 184 -
IS THERE A ROLE FOR MINIMAL RESIDUAL DISEASE MONITORING IN FOLLICULAR LYMPHOMA IN THE CHEMO-IMMUNOTHERAPY ERA?
3395PDF: 1291HTML: 2228Fi.1 Gritti.Rambaldi: 208 -
CAR-T CELL THERAPY FOR FOLLICULAR LYMPHOMAS CAR-T and Follicular Lymphoma
2328PDF: 1857HTML: 146 -
IMMUNOGLOBULIN GENE REPERTOIRE IN CHRONIC LYMPHOCYTIC LEUKEMIA: INSIGHT INTO ANTIGEN SELECTION AND MICROENVIRONMENTAL INTERACTIONS
3087PDF: 883HTML: 7172Kost Fig1: 190Kost Fig 2: 183Kost Fig3: 180Kost Fig 4: 195Kost Fig5: 190Kost fig 6: 176 -
FDG-PET SCAN: A NEW PARADIGM FOR FOLLICULAR LYMPHOMA MANAGEMENT.
3329PDF: 1247HTML: 2208 -
OUTCOME OF PATIENTS WITH DIFFUSE LARGE B-CELL LYMPHOMA RELAPSING AFTER AUTOLOGOUS TRANSPLANT BEFORE AVAILABILITY OF CAR-T CELL TREATMENT Outcome of DLBCL patients relapsing after ASCT
1333HTML: 324PDF: 952Suppl. Files: 468 -
CAR-T CELLS IN CHRONIC LYMPHOCYTIC LEUKEMIA CAR-T and CLL
3684PDF: 1614HTML: 80 -
NOVEL AGENTS AND EMERGING STRATEGIES FOR TARGETING THE B-CELL RECEPTOR PATHWAY IN CLL
2545PDF: 846HTML: 8895Efremov 1: 234Efremov 2: 198 -
TREATMENT OUTCOMES AND CLINICAL RELEVANCE IN PATIENTS WITH DOUBLE EXPRESSOR DLBCL Sirapat Rungwittayatiwat1, Paisarn Boonsakan2, Pichika Chantrathammachart1, Teeraya Puavilai1, Sulada Pukiat1, Sithakom Phusanti1,3, Kochawan Boonyawat1, Pathawut Wacharapornin1, Pantep Angchaisuksiri1, Artit Ungkanont1,3, Suporn Chuncharunee1 Pimjai Niparuck1
1182PDF: 537HTML: 211 -
PERIPHERAL NERVOUS SYSTEM INVOLVEMENT IN LYMPHOPROLIFERATIVE DISORDERS
1774PDF: 881HTML: 383Fig1: 236Fig.2: 255Fig. 3: 186Fig. 5: 198Fig. 4: 227 -
COVID-19 IN CHILDREN AND ADOLESCENT: CHARACTERISTICS AND SPECIFICITIES IN IMMUNOCOMPETENT AND ONCOHEMATOLOGICAL PATIENTS COVID-19 IN CHILDREN AND ADOLESCENT.
2517PDF: 943HTML: 304 -
HODGKIN LYMPHOMA IN OLDER PATIENTS: AN ORPHAN DISEASE?
2911PDF: 1369HTML: 3574Untitled: 194Untitled: 210Untitled: 182







